MMED (Minimed Group) Total Receivables: $653 Mil (As of Jan. 2026)


MMED Minimed Group Inc MMED
15 GF Score
Price $14.28
! 1 Warning Sign
View Full Analysis

What is Minimed Group Total Receivables?

Minimed Group MMED +0.14% 15 Total Receivables is $653 Mil as of Jan. 2026. GuruFocus rates MMED with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Minimed Group's Total Receivables for the quarter that ended in Jan. 2026 was $653 Mil.

Minimed Group Total Receivables Related Terms

Minimed Group Total Receivables Historical Data

* Premium members only.

The historical data trend for Minimed Group's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minimed Group Total Receivables Chart

Minimed Group Annual Data
Trend Apr23 Apr24 Apr25
Total Receivables
0.00 507.00 570.00

Minimed Group Quarterly Data
Apr24 Jan25 Apr25 Oct25 Jan26
Total Receivables 507.00 0.00 570.00 166.00 653.00
MMED
15GF Score
Minimed Group Inc MMED
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Minimed Group Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $653 Mil mean?
Minimed Group (MMED) has a Total Receivables of $653 Mil as of Jan. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Minimed Group and its competitors.
Is Minimed Group's Total Receivables too high?
Minimed Group's current Total Receivables is $653 Mil. Overall, Minimed Group has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's Total Receivables compare to ICUI and WRBY?
Minimed Group's Total Receivables of $653 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Devices & Instruments company?
A good Total Receivables depends on the Medical Devices & Instruments industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Minimed Group and its competitors. Minimed Group's current Total Receivables is $653 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (MMED) has a current Total Receivables of $653 Mil. The current Total Receivables is $653 Mil. Minimed Group's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Minimed Group (MMED), the current Total Receivables is $653 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minimed Group Business Description

Other Exchanges B8S:Germany
Address 18000 Devonshire Street, Northridge, CA, USA, 91325
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
15GF Score

Get the complete analysis for MMED

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.28
Price